한약재들의 안지오텐신 전환효소 억제 작용 검색

In vitro Screening of Oriental Medicinal Plants for Inhibitory Effects on Angiotensin-converting Enzyme

  • 강대길 (원광대학교 한의학전문대학원 신약개발학과) ;
  • 오현철 (원광대학교 한의학전문대학원 신약개발학과) ;
  • 손은진 (원광대학교 한의학전문대학원 신약개발학과) ;
  • 권태오 (원광대학교 생명자원과학대학) ;
  • 이호섭 (원광대학교 한의학전문대학원 신약개발학과)
  • 발행 : 2001.06.01

초록

국내에서 많이 사용되는 한약재 51종을 극성에 따라 4가지 용매로 분획한 후 안지오텐신 전환 요소 활성도 억제를 검색한 결과 다음과 같은 결과를 얻었다. 1. 202종의 분획중 $400{\;}\mu\textrm{g}/ml$의 농도에서 안지오텐신 전환효소 활성도를 50% 이상 억제한 추출물 수는 26종이었고, 90% 이상 억제한 추출물 수는 4종이었다. 2. 대부분 추출물의 $IC_{50}$ 수치는 $300-400{\;}\mu\textrm{g}/ml$ 이었으나 택사의 물층, 황련의 buthanol, 물 추출물과 단삼의 ethylacetate, buthanol 추출물, 토사자의 ethylacetate 추출물 등은 6종의 추출물은 $200{\;}\mu\textrm{g}/ml$ 이하의 $IC_{50}$을 보였다. 이상과 같은 결과로 보아 많은 한약재들의 항고혈압 효과는 부분적으로 안지오텐신 전환효소를 억제하는 효과에 의한 것으로 여겨진다.

Objective : Oriental medicinal plants reported to be used as anti-hypertensive drugs have been in vitro screened for inhibitory effects on angiotensin-converting enzyme (ACE). Methods : The bioassay is based on inhibition of plasma angiotensin-converting enzyme, as measured from the enzymatic cleavage of the Hip-His-Leu substrate into His-Leu. The plant material is extracted with hexane, ethylacetate, n-buthanol and water separately. Results : In total, 51 species (202 extracts) have been investigated and $400{\;}\mu\textrm{g}/ml$ of the solvent extracts from 26 extracts inhibit the enzyme activities by more than 50%. Among them, four samples of two plant species (buthanol and ethylacetate extracts of Salvia miltiorrhiza and buthanol and water extracts of Jeffersonia dubia) were found to posses a high ACE inhibition ability more than 90%. Conclusion : These results suggested that many Oriental medicinal plants have a antihypertensive effects by inhibition of ACE.

키워드

참고문헌

  1. Annu. Rev. Biochem. v.45 Angiotensin-converting enzyme and the regulation ov vasoactive peptides. Soffer, R.L.
  2. Biochem. Pharmacol v.20 no.7 Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II. Stewart, J.M.;Ferreira, S.H.;Greene, L.J.
  3. Kor. J. Pharmacog. v.12 no.1 Screning of Plant Materials for the inhibitory activities against angiotensin converting enzyme. Yun, H.S.;Chung, S.H.;Han, B.H.
  4. Chem. Pharm. Bull. v.32 no.9 Inhibitors of angiotensin converting enzyme in crude drugs I. Inokuchi, J.;Okabe, H.;Yamuauchi, T.;Nagamatsu, A.
  5. Life Sciences. v.38 Antihypertensive substance in seeds of Areca catechu L. Inokuchi, J.;Okabe, H.;Yamauchi, T.;Nagamatsu, A.;Nonaka, G.;Nishioka, I.
  6. J. Ethnopharmacol. v.60 Ethnomedical information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India) Nyman, U.;Joshi, P.;Madsen, L.B.Pederses, T.B.;Pinstrup, M.;Rajasekharan, S.;George, V.;Pushpangadan, P.
  7. J. Ethnopharmacol. v.58 Plants from reunion island with alleged antihypertensive and diuretic effects-an experimental and ethnobotanical evaluation. Adsersen, A.;Adsersen, H.
  8. J. Ethnopharmacol. v.68 Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. Duncan, A.C.;J ger AK;van Stan J.
  9. J. Ethnopharmacol. v.48 In vitro screening of traditional medicines for anti-hypertensive effect based on inhibition of the angiotensin converting enzyme. Hansen, K.;Nymann, U.;Smitt, U.W.;Adsersen, A.;Gudiksen, L.;Rajasekharan, S.;Pushpangadan, P.
  10. J. Natl. Prod. v.51 Chemical and pharmaceutical studies on medicinal plants in Paraguay. Geraniin; an angiotensin-converting enzyme inhibitor from 'Paraparai mi', Phyllanthanthus niruri. Ueno. H.;Horie, S.;Nishi, Y.;Shogawa, H.;Kawasaki, M.;Suzuki, S.;Hayashi, T.;Arisawa, M.;Shimizu, M.;Yoshizaki, M.;Mirita, N.
  11. Planta Med. v.58 ACE-inhibitory procyanidins from Lespedeza capitata. Wagner, H.;Elbl, G.
  12. Pharmaceutical Pharmacol. Lett. v.1 Evaluation of natural products as inhibitors of angiotensin I-converting enzyme (ACE). Wagner, H.;Elbl, G.;Lotter, H.;Guinea, M.
  13. 한국식품과학회지 v.25 no.3 한국산 녹차로 부터 분리한 Flavan-3-ol 화합물의 angiotensin converting enzyme 저해 효과 조영재;안봉천;최청
  14. J. Natl. Prod. v.50 no.4 Inhibitory effects of various flavonoids isolated from leaves of persimon on angiotensin-converting enzyme activity. Kameda, K.;Takaku, T.;Okuda, H.;Kimura, Y.;Okuda, T.;Hatano, T.
  15. J. Natl. Prod. v.55 no.5 Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum. Chen, C.H.;Lin, J.Y.
  16. Shoyakugaku Zassi. v.41 Studies on the crude drug containing the angiotensin-converting enzyme inhibitors I. On the active principles of Lycium chinense Muller. Morota, T.;Sasaki, H.;Chin, M.;Sato, T.;Katayama, N.;Fukuyama, K.;Mitsuhashi, H.
  17. Chem. Pharm. Bull. v.34 no.7 Angiotensin converting enzyme-inhibitory triterpenes from Gaboderma lucidum. Morigiwa, A.;Kitabatake, K.;Fujimoto, Y.;Ikekawa, N.
  18. 한국식품과학회지 v.30 no.6 Chitosan을 리고당의 안지오텐신 전환효소 활성 억제 및 SHR에서의 고혈압 억제 특성 홍상필;김명희;오세욱;한찬규;김용현
  19. 한국식품과학회지 v.29 no.6 $\kappa$-Casein의 chymosin, pepsin lac trypsin 가수 분해물에 대한 안지오텐신 변환 효소 저해효과의 탐색 오세종;김세헌;김상교;백영진;조경현
  20. Hypertension. v.7 no.2 An improved fluorometric assay of rat serum and plasma converting enzyme. Santos, R.A.;Krieger, E.M.;Greene, L.J>
  21. Brazillian J. Med. Biol. Research. v.33 Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats. Oliveira, E.M.;Santos, R.A.S.;Krieger, J.E.
  22. J. Ethnophamacol. v.66 The antihypertensive effect of galic (Allium sativum) in the rat two-kidney, one-clip Goldblatt medel. Al-Zqttan, K.K.;Alnaqeeb, M.A.;Ali, M.
  23. 약제학회지 v.8 no.3 오가피 ethanol extract의 실험적 신성 고혈압에 미치는 영향 이세규;고석태;임동윤
  24. 동의생리학회지 v.11 no.2 부자 전탕액 투여가 실험적 신성 고혈압 백서 및 자발적 고혈압 백서의 신장 기능에 미치는 영향 노진구;이호섭;류도곤
  25. 원광한의학 v.3 no.1 신수 숙지황 수침이 정상 및 실험적 신성 고혈압 백서의 신장 기능에 미치는 영향 박정배;박희수;김홍일;이호섭;김경식
  26. Chinese drugs of plant origin. Tang, W.;Eisenbrand, G.
  27. Cancer Lett. v.58 no.1 Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Iizuka, N.;Miyamoto, K.;Hazama, S.;Yoshino, S.;Yoshimura, K.;Okita, K.;Fukumoto, T.;Yamamoto, S.;Tangoku, A.;Oka, M.
  28. Eur. J. Pharmacol. v.399 no.2;3 Vasorelaxant and antiprokiferative effects of berberine. Ko, W.H.;Yao, X.Q.;Lau, C.W.;Law, W.I.;Chen, Z.Y.;Kwok, W.;Ho, K.;Huang, Y.
  29. Pharmacology. v.59 no.6 The antihypertensive effect of the berberine derivative 6-protoberberine in spotaneously hypertensive rats. Liu, J.C.;Chan, P.;Chen, Y.J.;Tomlinson, B.;Hong, S.H.;Cheng, J.T.
  30. Arch. Immunol. Ther. Exp. (Warsz). v.20 no.6 The effect of berberine sulfate on healthy mice infected with Candida albicans. Mirska, I.;Kedzia, H.;Kowalewski, Z.;Kedzia, W.